活动剂量对接受机械通气的危重患者结局的影响:基于TEAM试验数据的目标试验模拟
本研究基于TEAM试验数据,采用目标试验模拟方法评估活动「剂量」对28天死亡率的影响,纳入741例接受有创机械通气的成人ICU患者,中位年龄62岁(IQR 51-71),37%为女性。模拟不同活动时长阈值与每日最高IMS阈值组合的干预,采用g-formula校正基线和时变混杂因素。结果显示,当仅达到较低活动水平(IMS为2)时,延长活动时间(≤20分钟)与更差结局相关(RR 1.33,95%CI 1.10-1.63);而当某日达到IMS>4时,延长活动时间未增加死亡率(RR 1.13,95%CI 0.96-1.46,未达统计学显著)。结论提示,在仅能达到较低IMS水平时延长活动时间与28天死亡率增加相关。
要点
- 在741例接受有创机械通气的成人ICU患者中,当活动时长≤20分钟且仅达到IMS 2时,延长活动时间与28天死亡率升高相关(RR 1.33,95%CI 1.10-1.63)。
- 当某日达到IMS>4时,延长活动时间(≤20分钟)与自然病程相比未增加28天死亡率(RR 1.13,95%CI 0.96-1.46,未达统计学显著)。
- 目标试验模拟采用g-formula校正基线和时变混杂因素,评估不同活动时长阈值与每日最高IMS阈值组合的模拟干预。
- 研究纳入人群为TEAM试验中的成人ICU患者,均接受有创机械通气,中位年龄62岁(IQR 51-71),37%为女性。
适用人群与场景
- TEAM试验纳入的成人ICU患者,均接受有创机械通气(中位年龄62岁,IQR 51-71;37%为女性)。
研究设计与关键结果
- 研究类型为目标试验模拟,基于TEAM试验数据,纳入741例接受有创机械通气的成人ICU患者,主要结局为28天死亡率。
- 当活动时长≤20分钟且仅达到IMS 2时,延长活动时间与更差结局相关(RR 1.33,95%CI 1.10-1.63)。
- 当某日达到IMS>4时,延长活动时间(≤20分钟)与自然病程相比未增加28天死亡率(RR 1.13,95%CI 0.96-1.46,未达统计学显著)。
证据类型、等级与局限
- 证据类型:基于随机对照试验数据的目标试验模拟(per-protocol效应估计)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在仅能达到较低IMS水平时延长活动时间与28天死亡率增加相关,提示活动剂量需结合所达到的活动水平考量。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Variability in the outcomes of mobilization interventions is expected due to their complexity, and one of the post hoc hypotheses for the findings of the TEAM trial is the impact of "dosage" of mobilization on clinical outcomes.
OBJECTIVES: The aim of the present study is to understand the impact of the "dose" of mobilization on 28-day mortality of patients included in the TEAM trial.
METHODS: A target trial emulation estimating the per-protocol effect, which is the effect had all patients in the trial adhered to strategies with different "doses" and timing, was used. All patients included in the TEAM trial (adults in the intensive care unit [ICU] who were undergoing invasive mechanical ventilation) were included and the primary outcome was 28-day mortality. Simulated interventions combining different thresholds of duration of mobilization and different thresholds of highest ICU Mobility Scale (IMS) achieved in each day were assessed using g-formulas considering baseline and time-varying confounders.
MEASUREMENTS AND MAIN RESULTS: Overall, 741 patients were included, with a median age of 62 (IQR, 51-71) years; 37% were female. Prolonged mobilization time carried worse outcomes when lower levels of mobility were achieved (risk ratio [RR], 1.33 [95% CI, 1.10-1.63] for mobilization time ≤20 minutes and mobility scale of 2). When an IMS >4 was achieved on a given day, prolonged duration of mobilization did not increase mortality compared to natural course (RR, 1.13 [95% CI, 0.96-1.46] for mobilization time ≤20 minutes and IMS of 4).
CONCLUSIONS: Prolonged mobilization when only lower IMS levels could be achieved was associated with increased 28-day mortality.
参考来源
- Serpa Neto A, Bailey M, Seller D, et al. Impact of mobilization dose on outcome of critically ill patients receiving mechanical ventilation-a target trial emulation using data from the TEAM trial. Am J Respir Crit Care Med. 2026. PMID: 41738127. doi:10.1093/ajrccm/aamaf109
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。